Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-09-20

Clinical Trial Update: IRB-HSR# 15084 A Prospective, Unblinded, Controlled Study to Evaluate the Effect of the ITPR in Patients Undergoing OPCAB Surgery [Phase 2]

View source ↗

Summary

Phase 2 prospective, unblinded, controlled study evaluating the effect of the ITPR in patients undergoing off-pump coronary artery bypass grafting (CABG).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Virginia | Conditions: CABG | Phase 2 | Status: UNKNOWN